Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury

Apoptosis

Volumn 20, Issue 9, 2015, Pages 1150-1163

  Zhang, Mingming ^a   Wang, Chen ^a   Hu, Jianqiang ^a   Lin, Jie ^a   Zhao, Zhijing ^a   Shen, Min ^a   Gao, Haokao ^a   Li, Na ^a   Liu, Min ^a   Zheng, Pengfei ^a   Qiu, Cuiting ^a   Gao, Erhe ^b   Wang, Haichang ^a   Sun, Dongdong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ischemia reperfusion injury, I R injury; Mitochondria; Notch3; Oncostatin M, OSM

Indexed keywords

COMPLEMENTARY DNA; NOTCH3 RECEPTOR; ONCOSTATIN M; ONCOSTATIN M RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; GROWTH INHIBITOR; NOTCH RECEPTOR; NOTCH3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOGENESIS; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE EXACERBATION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LENTIVIRINAE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; DRUG EFFECTS; GENETICS; HEART INFARCTION; METABOLISM; MYOCARDIAL REPERFUSION INJURY; RAT; TRANSGENIC MOUSE;

LENTIVIRUS; MUS;

ANIMALS; APOPTOSIS; GROWTH INHIBITORS; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; ONCOSTATIN M; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, NOTCH; RECEPTORS, ONCOSTATIN M; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84938978232     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-015-1148-7     Document Type: Article

References (32)

1. MacLellan WR, Schneider MD (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81(2):137-144
2. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM (1997) Apoptosis in human acute myocardial infarction. Circulation 95(2):320-323
3. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, Heusch G (2009) Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104(5):469-483
4. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381(9861):166-175
5. Nemir M, Pedrazzini T (2008) Functional role of Notch signaling in the developing and postnatal heart. J Mol Cell Cardiol 45(4):495-504
6. Wickremasinghe RG, Prentice AG, Steele AJ (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia 25(9):1400-1407
7. Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7(9):678-689
8. Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, Artavanis-Tsakonas S, Brugge JS (2010) Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci USA 107(11):5012-5017
9. Kratsios P, Catela C, Salimova E, Huth M, Berno V, Rosenthal N, Mourkioti F (2010) Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circ Res 106(3):559-572
10. Ge W, Ren J (2012) mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism. J Cell Mol Med 16(3):616-626
11. Gude NA, Emmanuel G, Wu W, Cottage CT, Fischer K, Quijada P, Muraski JA, Alvarez R, Rubio M, Schaefer E, Sussman MA (2008) Activation of Notch-mediated protective signaling in the myocardium. Circ Res 102(9):1025-1035
12. Guha S, Cullen JP, Morrow D, Colombo A, Lally C, Walls D, Redmond EM, Cahill PA (2011) Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival. Basic Res Cardiol 106(5):773-785
13. Pei H, Yu Q, Xue Q, Guo Y, Sun L, Hong Z, Han H, Gao E, Qu Y, Tao L (2013) Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidatie/nitrative stress. Basic Res Cardiol 108(5):373
14. Loomes KM, Taichman DB, Glover CL, Williams PT, Markowitz JE, Piccoli DA, Baldwin HS, Oakey RJ (2002) Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 112(2):181-189
15. Tanaka M, Miyajima A, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39-52
16. Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M, Roehle R, Maurer G, Huber K, Wojta J (2005) Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation 111(15):1938-1945
17. Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, WietelmannA Tanaka M, Lörchner H, Schimanski S, Szibor M, Warnecke H, Braun T (2011) Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9(5):420-432
18. Gomez-Lechon MJ (1999) Oncostatin M: signal transduction and biological activity. Life Sci 65(20):2019-2030
19. Guo L, Chen C, Shi M, Wang F, Chen X, Diao D, Hu M, Yu M, Qian L, Guo N (2013) Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 32(45):5272-5282
20. Sun D, Huang J, Zhang Z, Gao H, Li J, Shen M, Cao F, Wang H (2012) Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS ONE 7(3):e33491
21. Mellin V, Isabelle M, Oudot A, Vergely-Vandriesse C, Monteil C, Di Meglio B, Henry JP, Dautreaux B, Rochette L, Thuillez C, Mulder P (2005) Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur Heart J 26(15):1544-1550
22. Vives-Bauza C, Starkov A, Garcia-Arumi E (2007) Measurements of the antioxidant enzyme activities of superoxide dismutase, catalase, and glutathione peroxidase. Methods Cell Biol 80:379-393
23. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568(1-3):213-221
24. Si R, Tao L, Zhang HF, Yu QJ, Zhang R, Lv AL, Zhou N, Cao F, Guo WY, Ren J, Wang HC, Gao F (2011) Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 50(1):16-24
25. Lawlor MA, Alessi DR (2001) PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903-2910
26. Rondelet B, Dewachter C, Kerbaul F, Kang X, Fesler P, Brimioulle S, Naeije R, Dewachter L (2012) Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Eur Heart J 33(8):1017-1026
27. Miller BA, Hoffman NE, Merali S, Zhang XQ, Wang J, Rajan S, Shanmughapriya S, Gao E, Barrero CA, Mallilankaraman K, Song J, Gu T, Hirschler-Laszkiewicz I, Koch WJ, Feldman AM, Madesh M, Cheung JY (2014) TRPM2 channels protect against cardiac ischemia-reperfusion injury: role of mitochondria. J Biol Chem 289(11):7615-7629
28. Woodman OL, Long R, Pons S, Eychenne N, Berdeaux A, Morin D (2014) The cardioprotectant 3′,4′-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats. Pharmacol Res 81:26-33
29. Rocha M, Apostolova N, Herance JR, Rovira-Llopis S, Hernandez-Mijares A, Victor VM (2014) Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes. Med Res Rev 34(1):160-189
30. Balaban RS (2012) Perspectives on: SGP symposium on mitochondrial physiology and medicine: metabolic homeostasis of the heart. J Gen Physiol 139(6):407-414
31. Padmalayam I (2012) Targeting mitochondrial oxidative stress through lipoic acid synthase: a novel strategy to manage diabetic cardiovascular disease. Cardiovasc Hematol Agents Med Chem 10(3):223-233
32. Jager S, Handschin C, St-Pierre J, Spiegelman BM (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 104(29):12017-12022